Philip Morris International Inc. operates as a tobacco company. The company offers cigarettes and smoke-free products, including heat-not-burn, e-vapor, and oral nicotine products under the IQOS, VEEV, and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness products. The company was incorporated in 1987 and is headquartered in Stamford, Connecticut.
Philip Morris implemented a new reporting structure effective January 1, 2026, replacing four geographic reportable segments with International Smoke Free, International Combustibles and U.S. segments.
FDA grants modified risk orders for 20 ZYN nicotine pouch products
KEY STEP
On June 30, 2026, the U.S. Food and Drug Administration issued modified risk granted orders for 20 ZYN nicotine pouch products. The decision allows specific authorized claims describing lower risks of several smoking related diseases when adult smokers switch completely from cigarettes to these ZYN products. These were the first modified risk orders granted to nicotine pouches.
FDA authorizes 11 ZYN ULTRA nicotine pouch products
KEY STEP
On August 21, 2026, the U.S. Food and Drug Administration issued marketing granted orders for 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA. The authorizations covered the 9 mg product range and one 11 mg Smooth variant. Additional 11 mg variants remained under scientific review.